BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $107 at Credit Suisse on Positive CHMP Opinion

Go back to BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $107 at Credit Suisse on Positive CHMP Opinion
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 54.66 +1.34 (2.51%)
Previous Close $53.32    52 Week High $108.96 
Open $53.32    52 Week Low $62.12 
Day High $55.00    P/E N/A 
Day Low $53.01    EPS $-1.27 
Volume 2,268,035